Purpose of this study is to determine the safety and efficacy of topical applications of NB-001 as compared to placebo for the treatment of recurrent herpes labialis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
1,000
Time to healing as assessed by the subject.
Percent of subjects with healing by days 3, 4,and 5 as assessed by the subject.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Medical Affiliated Research Center, Inc.
Huntsville, Alabama, United States
Advanced Clinical Research Institute
Anaheim, California, United States
Westlake Medical Research
Westlake Village, California, United States
Front Range Clinical Research
Wheat Ridge, Colorado, United States
The Savin Center, PC
New Haven, Connecticut, United States
Clinical Research of West Florida
Clearwater, Florida, United States
Clinical Physiology Associates
Fort Myers, Florida, United States
Suncoast Clinical Research
New Port Richey, Florida, United States
Advanced Clinical Research, Inc.
Boise, Idaho, United States
DermResearch, PLCC
Louisville, Kentucky, United States
...and 18 more locations